defiteli价格

Defiteli () is a single-stranded oligonucleotide mixture with anti-thrombotic and fibrinolysis-promoting effects. In recent years, multiple clinical study results have shown that defiteli is a safe and effective drug for the prevention and treatment of hepatic veno-occlusive disease after HSCT.

On March 30, 2016, the FDA approved defibrotide (defibrotide sodium) for the treatment of adult and pediatric patients with hepatic veno-occlusive disease (VOD), also known as sinusoidal obstructive syndrome (SOS), and renal or pulmonary dysfunction following hematopoietic stem cell transplantation (HSCT).

The recommended dose of defiteli for adult and pediatric patients is 6.25 mg/kg administered every 6 hours as a 2-hour intravenous infusion. Defibrotide was administered for a minimum of 21 days. If signs and symptoms of hepatic VOD have not resolved after 21 days, continue defiteli until resolution of VOD or until a maximum of 60 days. defiteli must be diluted before infusion.

What is the price of defiteli? Since it has not yet been launched in my country, patients can only purchase the overseas version of Defiteli. The current price of Defiteli on the market is around 22,000$, which may be slightly different due to the exchange rate. Please consult the medical companion passenger service for details.

Defibrotide () is an adenosine receptor agonist with multiple effects. It can reduce the expression of cell adhesion molecules on the surface of endothelial cells, thereby reducing the adhesion of leukocytes to vascular endothelial cells and reducing the inflammatory damage of endothelial cells. In addition, defiteli can also promote the release of prostaglandin I2 (PGI2) and prostaglandin E2 (PGE2), thereby causing blood vessel dilation, inhibiting platelet aggregation, and reducing ischemic damage. If you need to buy defiteli, our medical partner travel overseas medical service company will help you.